FDA Leadership Changes Tune On Pediatric Priority Review Voucher Benefit

 
• By Sarah Karlin-Smith
older female doctor talks to young child and parent
FDA leaders have a new message on the value of the rare pediatric PRV program with the reauthorization deadline nearing. • Source: Shutterstock

More from Rare Diseases

More from Pink Sheet